Sanofi enters into $30M partnership with digital therapeutics company

The latest stories trending on MedCity News.

Not rendering correctly? View this email as a web page here. TOP STORIES Sanofi and DarioHealth team up on digital health tools for chronic conditions Sanofi and digital therapeutics company DarioHealth will work together to promote the tech firm's offerings for the management of chronic diseases. Under the $30 million, multi-year agreement, the partners will also develop new technology tools. SPONSORED Diversity through accessibility: How in-home clinical trials can enroll more patients of color From Workpath & MedCity News Clinical trials have long struggled to enroll participants that reflect the demographics of a patient population, but new models can change that. AbbVie makes neuro drug connection with $130M Syndesi Therapeutics acquisition By Frank Vinluan Tuesday, March 1, 2022 7:04 PM AbbVie has acquired Syndesi Therapeutics, an early clinical neuroscience startup developing drugs that have potential applications in a range of cognitive disorders. Syndesi is based on research from Belgian pharmaceutical company UCB. Read more » A mental health crisis on the horizon: Four ways to improve the U.S. behavioral care system By Christine Carville Tuesday, March 1, 2022 5:36 PM Covid-19 has driven increases in mental health-related emergency room visits, suspected suicide attempts, and reported cases of depression and anxiety among all age groups, particularly children. Read more » Synapse Medicine adds $28M for its platform supporting proper medication use By Michael Schroeder Tuesday, March 1, 2022 4:44 PM European venture firm Korelya Capital led the funding round, Synapse's third in as many years, bringing the total amount the startup has raised to $40 million. Read more » Sanofi and DarioHealth team up on digital health tools for chronic conditions By Frank Vinluan Tuesday, March 1, 2022 4:11 PM Sanofi and digital therapeutics company DarioHealth will work together to promote the tech firm's offerings for the management of chronic diseases. Under the $30 million, multi-year agreement, the partners will also develop new technology tools. Read more » Which pharmatech startups will present at MedCity INVEST's Pitch Perfect contest? By Stephanie Baum Tuesday, March 1, 2022 4:02 PM Five companies will present to a group of investor judges. They will be evaluated on criteria such as business idea, market opportunity, and revenue model. Read more » Yale study: Disparities in 30-day readmission rate for dual-eligibles not connected to SDOH factors By Emma Bardin Tuesday, March 1, 2022 3:56 PM A recent Yale study found no correlation between 30-day hospital readmissions for dually eligible Medicare Medicaid patients and census reported social determinants of health, though the study anticipated it would. The lack of correlation could be due to additional SDOH beyond the scope of the study. Read more » What to expect from nurse practitioners in 2022 By Sylvia Hastanan Tuesday, March 1, 2022 3:34 PM Prior to the pandemic, about half of U.S. states had given nurse practitioners full practice authority. Since then, even more states have issued executive orders to allow NPs to take on more responsibility during the pandemic – an emergency response put in place to help address new challenges. Read more » A clarion call to improve mental health treatment post-Covid-19 By Sara Rogers Tuesday, March 1, 2022 1:23 PM Leveraging a precision prescribing platform with embedded genomic analysis will help physicians improve care and reduce costs by providing valuable information to inform mental health medication choices that can deliver treatment success for their patients from the start. Read more » ViVE Q&A: What can healthcare organizations do to repel ransomware attacks? [Sponsored] By Stephanie Baum Tuesday, March 1, 2022 12:25 PM Cybersecurity will be an important part of the conversation at the ViVE conference by HLTH and CHIME, March 6-9 in Miami Beach. An interview with a senior adviser from the Cybersecurity and Infrastructure Security Agency highlights how payers, providers and health tech companies can better protect patient data. Read more » J&J, Legend win FDA nod for cell therapy challenger to BMS in multiple myeloma By Frank Vinluan Tuesday, March 1, 2022 11:01 AM Approval of the Johnson & Johnson and Legend Biotech cell therapy, Carvykti, marks the second CAR T-cell therapy to clear the regulatory bar for multiple myeloma. The FDA approved Bristol Myers Squibb's cell therapy Abecma last year. Read more » MedCity INVEST 2022   MedCity INVEST 2022 at The Ritz Carlton Chicago is a 3 day gathering with numerous opportunities for in-person networking and learning around the latest technologies and investment trends from VCs and successful entrepreneurs.   Register Now MedCity News   611 Broadway    New York,  NY   10012   United States You received this email because you are subscribed to MedCity Daily Digest from MedCity News. Update your email preferences to choose the types of emails you receive.  Unsubscribe from all future emails